ES8800153A1 - Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina. - Google Patents
Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina.Info
- Publication number
- ES8800153A1 ES8800153A1 ES546799A ES546799A ES8800153A1 ES 8800153 A1 ES8800153 A1 ES 8800153A1 ES 546799 A ES546799 A ES 546799A ES 546799 A ES546799 A ES 546799A ES 8800153 A1 ES8800153 A1 ES 8800153A1
- Authority
- ES
- Spain
- Prior art keywords
- weight
- preparation
- parts
- solid pharmaceutical
- nitrendipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- PVHUJELLJLJGLN-INIZCTEOSA-N (S)-nitrendipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC([N+]([O-])=O)=C1 PVHUJELLJLJGLN-INIZCTEOSA-N 0.000 title abstract 2
- 229960005425 nitrendipine Drugs 0.000 title abstract 2
- 239000007787 solid Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920002261 Corn starch Polymers 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000004141 Sodium laurylsulphate Substances 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
PROCEDIMIENTO PARA OBTENER FORMULACIONES MEDICINALES SOLIDAS DE NITRENDIPINA CRISTALINA. COMPRENDE: A) HACER REACCIONAR AL ESTER DEL ACIDO ILIDEN-BETA-CETOCARBOXILICO DE FORMULA (II), EN ETANOL, ENTRE 20 Y 120GC, PARA OBTENER NITRENDIPINA SOLIDA; B) GRANULAR A LA NITRENDIPINA SOLIDA, MEDIANTE SUSTANCIAS AUXILIARES Y PORTADORAS; Y C) TRANSFORMAR LA MASA EN TABLETAS, PILDORAS O GRAGESA PARA SU POSTERIOR APLICACION. SE UTILIZA COMO REDUCTOR DE LA PESION SANGUINEA. *FORMULA*
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19843433239 DE3433239A1 (de) | 1984-09-11 | 1984-09-11 | Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8800153A1 true ES8800153A1 (es) | 1987-10-16 |
| ES546799A0 ES546799A0 (es) | 1987-10-16 |
Family
ID=6245068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES546799A Expired ES8800153A1 (es) | 1984-09-11 | 1985-09-09 | Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4724141A (es) |
| EP (1) | EP0176773B1 (es) |
| JP (1) | JPH0761960B2 (es) |
| KR (1) | KR920006909B1 (es) |
| AT (1) | ATE48943T1 (es) |
| AU (1) | AU578114B2 (es) |
| CA (1) | CA1261271A (es) |
| DE (2) | DE3433239A1 (es) |
| DK (1) | DK411485A (es) |
| ES (1) | ES8800153A1 (es) |
| GR (1) | GR852176B (es) |
| IL (1) | IL76332A0 (es) |
| ZA (1) | ZA856916B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1178511B (it) * | 1984-09-14 | 1987-09-09 | Pharmatec Spa | Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio |
| US4771057A (en) * | 1986-02-03 | 1988-09-13 | University Of Alberta | Reduced pyridyl derivatives with cardiovascular regulating properties |
| DE3639073A1 (de) * | 1986-11-14 | 1988-05-26 | Klinge Co Chem Pharm Fab | Feste arzneizubereitungen und verfahren zu ihrer herstellung |
| US5190962A (en) * | 1990-03-13 | 1993-03-02 | Sepracor, Inc. | Treating hypertension |
| US5571827A (en) * | 1990-03-13 | 1996-11-05 | Sepracor Inc. | Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| FR2661611B1 (fr) * | 1990-05-04 | 1994-11-18 | Theramex | Nouvelles compositions pharmaceutiques a base de polycarbophil et leur procede d'obtention. |
| SI9300504A (en) * | 1993-09-28 | 1995-04-30 | Krka | Process for preparation solid dispersions and deposits of calcium antagonist dihidropyrimidine derivates and pharmaceutical compositions comprising the same |
| JP2713549B2 (ja) * | 1994-05-17 | 1998-02-16 | 財団法人工業技術研究院 | 防湿性漢方製剤 |
| JP2656727B2 (ja) * | 1994-05-17 | 1997-09-24 | 財団法人工業技術研究院 | 防湿性漢方顆粒製剤 |
| KR100690311B1 (ko) * | 1998-12-01 | 2007-03-09 | 닥터 레디스 래보러토리즈, 인코포레이티드 | 새로운 제약 조성물 및 그것의 제조방법 |
| JP4748839B2 (ja) * | 1999-03-25 | 2011-08-17 | 大塚製薬株式会社 | シロスタゾール製剤 |
| EG23951A (en) * | 1999-03-25 | 2008-01-29 | Otsuka Pharma Co Ltd | Cilostazol preparation |
| JP4334869B2 (ja) | 2000-12-01 | 2009-09-30 | 協和発酵キリン株式会社 | 溶解性または経口吸収性の改善された組成物 |
| FR2827517B1 (fr) * | 2001-07-23 | 2003-10-24 | Bioalliance Pharma | Systemes therapeutiques bioadhesifs a liberation prolongee |
| DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
| EP1837020A1 (en) | 2006-03-24 | 2007-09-26 | Bioalliance Pharma | Mucosal bioadhesive slow release carrier for delivering active principles |
| EP3002005A1 (en) | 2014-09-30 | 2016-04-06 | Molkerei Meggle Wasserburg GmbH & Co. Kg | Direct compression excipient based on lactose, cellulose and starch |
| AU2017226389B2 (en) | 2016-03-04 | 2023-02-02 | Taiho Pharmaceutical Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
| SG11202008435SA (en) | 2018-03-19 | 2020-10-29 | Taiho Pharmaceutical Co Ltd | Pharmaceutical composition including sodium alkyl sulfate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2837477A1 (de) * | 1978-08-28 | 1980-03-13 | Bayer Ag | Sila-substituierte 1,4-dihydropyridin- derivate |
| JPS5547615A (en) * | 1978-09-29 | 1980-04-04 | Taiyo Yakuhin Kogyo Kk | Stable solid drug of nifedipine |
| JPS56110612A (en) * | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Readily disintegrable and absorbable compression molded article of slightly soluble drug |
| DE3142853A1 (de) * | 1981-10-29 | 1983-05-11 | Bayer Ag, 5090 Leverkusen | Feste arzneizubereitungen mit nifedipin und verfahren zu ihrer herstellung |
| DE3212736A1 (de) * | 1982-04-06 | 1983-10-13 | Bayer Ag, 5090 Leverkusen | Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung |
| DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
-
1984
- 1984-09-11 DE DE19843433239 patent/DE3433239A1/de not_active Withdrawn
-
1985
- 1985-08-30 DE DE8585110921T patent/DE3574933D1/de not_active Expired - Lifetime
- 1985-08-30 EP EP85110921A patent/EP0176773B1/de not_active Expired
- 1985-08-30 AT AT85110921T patent/ATE48943T1/de not_active IP Right Cessation
- 1985-09-05 US US06/772,828 patent/US4724141A/en not_active Expired - Lifetime
- 1985-09-09 JP JP60197860A patent/JPH0761960B2/ja not_active Expired - Fee Related
- 1985-09-09 IL IL76332A patent/IL76332A0/xx not_active IP Right Cessation
- 1985-09-09 ES ES546799A patent/ES8800153A1/es not_active Expired
- 1985-09-09 CA CA000490274A patent/CA1261271A/en not_active Expired
- 1985-09-09 GR GR852176A patent/GR852176B/el unknown
- 1985-09-10 DK DK411485A patent/DK411485A/da not_active Application Discontinuation
- 1985-09-10 AU AU47335/85A patent/AU578114B2/en not_active Ceased
- 1985-09-10 KR KR1019850006587A patent/KR920006909B1/ko not_active Expired
- 1985-09-10 ZA ZA856916A patent/ZA856916B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0176773A1 (de) | 1986-04-09 |
| GR852176B (es) | 1986-01-10 |
| ATE48943T1 (de) | 1990-01-15 |
| IL76332A0 (en) | 1986-01-31 |
| KR920006909B1 (ko) | 1992-08-22 |
| CA1261271A (en) | 1989-09-26 |
| AU4733585A (en) | 1986-03-20 |
| DK411485D0 (da) | 1985-09-10 |
| JPH0761960B2 (ja) | 1995-07-05 |
| JPS6168431A (ja) | 1986-04-08 |
| ZA856916B (en) | 1986-04-30 |
| ES546799A0 (es) | 1987-10-16 |
| EP0176773B1 (de) | 1989-12-27 |
| KR860002270A (ko) | 1986-04-24 |
| DE3574933D1 (de) | 1990-02-01 |
| DK411485A (da) | 1986-03-12 |
| US4724141A (en) | 1988-02-09 |
| AU578114B2 (en) | 1988-10-13 |
| DE3433239A1 (de) | 1986-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8800153A1 (es) | Procedimiento para la obtencion de formulaciones medicionales solidas de nitrendipina cristalina. | |
| HUT61989A (en) | Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient | |
| HUT47552A (en) | Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components | |
| HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| CA2159580A1 (en) | Pharmaceutical Compositions Containing Polyvinylpyrrolidone and a Tri-Ester and Process of Manufacture Thereof | |
| HUT51222A (en) | Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient | |
| RO91197B (ro) | Procedeu pentru prepararea unor derivati de piridazinamina | |
| HUT53359A (en) | Process for producing pharmaceutical compositions comprising oxooxazolinidyl cyclopentano benzene derivatives as active ingredient | |
| HUT47130A (en) | Process for producing 9alpha-hydroxysteroids, as well as 9(11)-dehydro derivatives and pharmaceutical compositions comprising these active ingredients | |
| GR3003187T3 (en) | A moisture stable solid valproic acid formulation and a method of preparing the same | |
| HUT61751A (en) | Process for producing benzofuran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| IL118366A0 (en) | Vitamin D derivatives a process for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT48247A (en) | Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components | |
| HUT48269A (en) | Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them | |
| ES8403494A1 (es) | "un procedimiento para la preparacion de derivados de s-adenosilmetionina". | |
| HUT53363A (en) | Process for producing new perhydroazacycloalkano(1,2-a)imidazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT49367A (en) | Process for producing aristeromycin/adenosine derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT53897A (en) | Process for producing benzopyran derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT47243A (en) | Process for producing nitromethane derivatives, pharmaceuticals comprising such active ingredient, as well as thioethers | |
| HUT49598A (en) | Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT55394A (en) | Process for producing pirrolidino-piperazine-dion derivatives and pharmaceutical compositions containing them as active components | |
| HUT50334A (en) | Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient | |
| HUT58082A (en) | Process for producing chroman derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT59116A (en) | Process for producing oxazole derivatives and pharmaceutical compositions comprising oxazole derivatives as active ingredient | |
| HUT63151A (en) | Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970401 |